Loading insider details...
Beta
Latest Form 4 (Aug 12, 2026): Exercise/Conversion of 1,732 ICLR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | ICON PLC (ICLR) | Exercise/Conversion | 1,732 | n/a |
| Jun 15, 2026 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 15,000 | n/a |
| Jun 16, 2025 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 15,000 | n/a |
| Jun 17, 2024 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 15,000 | n/a |
| Jan 31, 2024 | ARCA biopharma, Inc. (ABIO) | Grant/Award | 6,000 | n/a |
| Dec 8, 2023 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 15,000 | n/a |
| Jun 20, 2023 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 15,000 | n/a |
| May 16, 2023 | Corvus Pharmaceuticals, Inc. (CRVS) | Purchase | 10,000 | $24.5K |
| Dec 19, 2022 | ARCA biopharma, Inc. (ABIO) | Grant/Award | 6,000 | n/a |
| Aug 15, 2022 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 15,000 | n/a |